Aktiespot

Lifeline Biotechnologies, Inc. (Lifeline BioTechnologies, Inc.) Aktie

LLBO

Geschlossen
$0.00080.0000 (0.00%)
Chart wird geladen...

Lifeline BioTechnologies, Inc.

Eröffnung0.0007
Hoch0.0009
Tief0.0004
Volumen554.22k
P/EN/A
Marktkapitalisierung3.48M
52-Wochen-Hoch0.0013
52-Wochen-Tief0.0001
Durchschn. Volumen569.66k
DividendeN/A
Beta304.17
EPS-0.0000

Über Lifeline Biotechnologies, Inc. (Lifeline BioTechnologies, Inc.) Aktie

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Unternehmensinformationen

Börse: OTC Markets OTCID (OID)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
1325 Airmotive Way
89502 Reno, United States
Telefon: + 775-852-3222

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: